Corindus Vascular Robotics (Formerly known as Corindus) Highlights Radiation Reduction At TCT Meeting

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Corindus Vascular Robotics, Inc. (OTCQB: CVRS), a leading developer of precision vascular robotics, will showcase its CorPath© Vascular Robotic System during the upcoming Transcatheter Cardiovascular Therapeutics (TCT) 2014 meeting, September 13 – 17 in Washington, D.C. Throughout the meeting, Corindus will highlight occupational safety and robotic precision during percutaneous coronary intervention (PCI) procedures, including radiation exposure reduction by robotic-assisted PCI.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC